Regenerative Medicines Market by Therapy (Tissue Engineering, Cell Therapy, Immunotherapy, and Gene Therapy), by Material (Synthetic Materials, Biologically Derived Materials, Genetically Engineered Materials, and Others), and by Application (Oncology, Orthopedic and Musculoskeletal Spine, Cardiovascular, Dermatology, Central Nervous System, Diabetes, and Others) - Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Global regenerative medicines market expected to generate revenue of around USD 26.30 billion by the end of 2024, growing at a CAGR of around 18.59% between 2017 and 2024. Regenerative medicines include the process of regenerating human cells, organs, and tissues to restore its normal function.

Request Brochure Request Discount

19-Jun-2018 | Number of pages: 110 | Report Code: ZMR-823 | Report Format : | Status : Published

Abstract

The report covers the forecast and analysis for the regenerative medicines market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the regenerative medicines market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the regenerative medicines market on a global level.

In order to give the users of this report a comprehensive view on the regenerative medicines market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product and regional expansion of major participants involved in the market.

Global Regenerative Medicines Market

The study provides a decisive view of the regenerative medicines market by segmenting it on the basis of product, therapy, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for regenerative medicines market based on all segments in all the regions and countries.

The report also includes detailed profiles of end players such as Acelity, Celgene Corporation, NuVasive, Inc., Vericel Corporation (Genzyme), StemCells, Inc., Japan Tissue Engineering Co., Ltd., Anika Therapeutics, Inc., Baxter International, Inc., DePuy Synthes, Inc., Medtronic, Inc., and Arthrex, Inc.

This report segments the global regenerative medicines market as follows:

Global Regenerative Medicines Market: Therapy Segment Analysis

  • Tissue Engineering
  • Cell Therapy
  • Immunotherapy
  • Gene Therapy

Global Regenerative Medicines Market: Material Segment Analysis

  • Synthetic Materials
  • Biologically Derived Materials
  • Genetically Engineered Materials
  • Others

Global Regenerative Medicines Market: Application Segment Analysis

  • Oncology
  • Orthopedic and Musculoskeletal Spine
  • Cardiovascular
  • Dermatology
  • Central Nervous System
  • Diabetes
  • Other Applications

Global Regenerative Medicines Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Peptide and Anticoagulant Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3130 | Report Format:

Global Peptide and Anticoagulant Drugs Market: Overview Peptides anticoagulant drugs are likely to have a wide range of applications in treating several diseases for example osteoporosis, cancer, cardiovascular, diabetes, and coagulation disorders. Peptides are basically molecules that are univ...Read More

Crohn’s Disease Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2024

Price : $ 3999.00 | Report Code: ZMR-3033 | Report Format:

Global Crohns Disease Market: Overview An inflammatory disease of bowel affecting any part of the Gastro-Intestinal Tract (GI Tract) is termed as Crohns disease. It is classified into a segment of chronic disease. Crohns disease is considered to impact nearly every part of an individuals life, a...Read More

Anti-Neoplastic Agents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-3024 | Report Format:

Global Anti-Neoplastic Agents Market: Overview Anti-neoplastic agents are primarily used as a first-line treatment for cancer therapy as well as in combination with radiation or surgical therapy. A lot of anti-neoplastic agents are accessible commercially for the therapy of various kinds of canc...Read More

Kidney Fibrosis Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-2989 | Report Format:

Global Kidney Fibrosis Treatment Market: Overview Fibrosis is the growth of extreme connective tissue owing to some injury or some disease. Disease in the kidney can cause kidney fibrosis. In this state, the kidneys fail to work properly which gradually leads to severe conditions. Kidney transpl...Read More

Oncology Based In-vivo CRO Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016–2024

Price : $ 3999.00 | Report Code: ZMR-2982 | Report Format:

Global Oncology Based In-vivo CRO Market: Overview CRO basically stands for contract research organization which presents research services to a pharmaceutical, biotechnology, and medical devices key players on the basis of the contract. CRO offers services such as clinical research, biologic as...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.